AQP4 and depressive symptom measurement: In particular, the first aforementioned case–control study [30] identified no differences in blood mRNA AQP4 expression among responders, patients who were not using drugs, and controls, whereas AQP4 expression was elevated in patients with treatment-resistant depression.